全文获取类型
收费全文 | 3270篇 |
免费 | 264篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 135篇 |
妇产科学 | 82篇 |
基础医学 | 117篇 |
口腔科学 | 115篇 |
临床医学 | 165篇 |
内科学 | 427篇 |
皮肤病学 | 14篇 |
神经病学 | 78篇 |
特种医学 | 171篇 |
外科学 | 169篇 |
综合类 | 25篇 |
预防医学 | 1896篇 |
眼科学 | 11篇 |
药学 | 23篇 |
肿瘤学 | 105篇 |
出版年
2023年 | 32篇 |
2022年 | 51篇 |
2021年 | 32篇 |
2020年 | 90篇 |
2019年 | 29篇 |
2018年 | 98篇 |
2017年 | 105篇 |
2016年 | 103篇 |
2015年 | 98篇 |
2014年 | 94篇 |
2013年 | 168篇 |
2012年 | 36篇 |
2011年 | 44篇 |
2010年 | 116篇 |
2009年 | 135篇 |
2008年 | 72篇 |
2007年 | 63篇 |
2006年 | 80篇 |
2005年 | 70篇 |
2004年 | 56篇 |
2003年 | 45篇 |
2002年 | 97篇 |
2001年 | 108篇 |
2000年 | 70篇 |
1999年 | 161篇 |
1998年 | 165篇 |
1997年 | 205篇 |
1996年 | 219篇 |
1995年 | 132篇 |
1994年 | 62篇 |
1993年 | 123篇 |
1992年 | 39篇 |
1991年 | 28篇 |
1990年 | 29篇 |
1989年 | 52篇 |
1988年 | 41篇 |
1987年 | 40篇 |
1986年 | 44篇 |
1985年 | 42篇 |
1984年 | 26篇 |
1983年 | 28篇 |
1982年 | 23篇 |
1981年 | 20篇 |
1980年 | 17篇 |
1979年 | 22篇 |
1977年 | 12篇 |
1976年 | 21篇 |
1975年 | 12篇 |
1974年 | 9篇 |
1967年 | 9篇 |
排序方式: 共有3538条查询结果,搜索用时 15 毫秒
141.
Kenneth Mangion David Carrick Jaclyn Carberry Ahmed Mahrous Christie McComb Hao Gao Xiayou Luo Keith Oldroyd Hany Eteiba Margaret McEntegart Mitchell Lindsay Mark Petrie Xiaodong Zhong Caroline Haig Colin Berry 《Lancet》2017
Background
Infarct size assessed early after acute ST-segment elevation myocardial infarction (STEMI) can overestimate the true extent of infarction, limiting its usefulness as a prognostic biomarker. Myocardial strain derived from displacement encoding with stimulated echoes (DENSE) cardiovascular magnetic resonance (CMR) provides information on myocardial contractility with high precision and accuracy. We hypothesised that the prognostic value of peak circumferential strain is higher than infarct size.Methods
In a prospective, single centre study, participants underwent 1·5T CMR 2 days and 6 months after myocardial infarction. The 5-SD technique was used to quantify late gadolinium enhancement (LGE) as proportion of left ventricular mass. Mid-left ventricular DENSE acquisitions were analysed using postprocessing software. During longer-term follow-up, major adverse cardiac events (MACE) were independently assessed by masked cardiologists. Participants provided written informed consent and ethics approval was given (reference 10/S0703/28). This study is registered with ClinicalTrials.gov, number NCT02072850.Findings
300 patients underwent CMR (mean age 58·6 years [SD 13·2], 237 men [79%], 118 anterior myocardial infarction [39%], 30 with diabetes [10%], 284 with normal flow [Thrombolysis in Myocardial Infarction grade 3] after percutaneous coronary intervention [95%]). 259 of these patients had DENSE acquired, of whom 21 (8%) experienced a MACE at 3 years' follow-up. DENSE and baseline LGE had reasonable power for prediction of adverse events (area under the curve [AUC] DENSE 0·712, p=0·001; AUC LGE 0·644, p=0·028). For MACE (receiver operating characteristic analysis), optimal cut-offs for peak circumferential strain using DENSE was ?10·51%, and LGE 24·05 g. Cox-regression analysis showed that DENSE (hazard ratio 1·175, 95% CI 0·036–1·334; p=0·012) offered an incremental prognostic benefit over LGE (1·040, 1·010–1·070; p=0·008) to predict MACE.Interpretation
DENSE-derived peak circumferential strain offers an incremental prognostic benefit over infarct size revealed by LGE to predict MACE; a cut-off of ?10·51% can identify STEMI patients at higher risk of events. This is the first time, to our knowledge, that CMR-derived strain has been shown to provide prognostic utility in patients with STEMI.Funding
This research was supported by project grants from the Chief Scientist Office (SC01), Medical Research Scotland (343 FRG), and the British Heart Foundation (BHF-PG/14/64/31043). 相似文献142.
Harrison J; Kappas A; Levere RD; Lutton JD; Chertkov JL; Jiang S; Abraham NG 《Blood》1993,82(12):3574-3579
The ability of combination treatment with erythropoietin (Epo) and heme to rescue hematopoietic activity in mice from the suppressive effect of azidothymidine (AZT) was determined. Exposure of mice to AZT for 5 weeks produced marked anemia, thrombocytopenia, neutropenia, and weight loss, whereas mice that received Epo and heme for 3 subsequent weeks showed significant alleviation of AZT cytotoxicity. Treatment with Epo (10 U for 5 times/week) stimulated hematopoietic recovery in the AZT- treated animals and reduced the severe anemia and thrombocytopenia by 3 weeks. Administration of a lower Epo dose (1 U Epo) resulted in only a modest retardation of AZT-induced anemia, although, when combined with heme, there was a great improvement in recovery of erythropoiesis. The combination of heme with Epo (10 U) produced the optimum response, resulting in almost normal recovery of bone marrow cellularity as well as recovery of burst-forming units-erythroid (BFU-E) and splenic hematopoietic progenitor content (colony-forming unit-spleen [CFU-S]) by the end of 3 weeks of post-AZT treatment. Treatment with heme alone markedly enhanced the recovery of BFU-E and CFU-S, as well as body weight post-AZT; however, this recovery was not to the extent seen in combination with Epo (10 U). Long-term bone marrow cultures (LTBMCs) established from mice exposed to AZT for 8 weeks showed a marked reduction in cellularity and this was completely alleviated when mice received heme and Epo (10 U) for 3 weeks after 5 weeks of AZT administration. The additive effect of heme and Epo was seen in BFU-E production, as well as in CFU-S production, in LTBMCs. Thus, heme exerts a significant protective effect on hematopoietic progenitors in vivo and may be of potential clinical use in combination with Epo to promote effective erythropoiesis in the setting of AZT therapy. 相似文献
143.
144.
145.
146.
147.
148.
David C. Frankenfield MS RD CNSD Abigail Coleman MS RD CNSD Shoaib Alam MD Robert N. Cooney MD 《JPEN. Journal of parenteral and enteral nutrition》2009,33(1):27-36
Background: Prediction of metabolic rate is an important part of the nutrition assessment of critically ill patients, yet there are limited data regarding the best equation to use to make this prediction. Methods: Standardized indirect calorimetry measurements were made in 202 ventilated, adult critical care patients, and resting metabolic rate was calculated using the following equations: Penn State equation, Faisy, Brandi, Swinamer, Ireton‐Jones, Mifflin, Mifflin × 1.25, Harris Benedict, Harris Benedict × 1.25, Harris Benedict using adjusted weight for obesity, and each of the adjusted weight versions of Harris Benedict × 1.25. The subjects were subgrouped by age and obesity status (young nonobese, young obese, elderly nonobese, elderly obese). Performance of each equation was assessed using bias, precision, and accuracy rate statistics. Results: Accuracy rates in the study population ranged from 67% for the Penn State equation to 18% for the weight‐adjusted Harris Benedict equation (without multiplication). Within subgroups, the highest accuracy rate was 77% in the elderly nonobese using the Penn State equation and the lowest was 0% for the weight‐adjusted Harris Benedict equation. The Penn State equation was the only equation that was unbiased and precise across all subgroups. The obese elderly group was the most difficult to predict. Therefore, a separate regression was computed for this group: Mifflin(0.71) + Tmax(85) + Ve(64) – 3085. Conclusions: The Penn State equation provides the most accurate assessment of metabolic rate in critically ill patients if indirect calorimetry is unavailable. An alternate form of this equation for elderly obese patients is presented, but has yet to be validated. 相似文献
149.
150.